To inject insulin safely and effectively, it's important to follow your doctor's advice and remember a few key steps.
A major challenge for people who have a form of diabetes is the need to regulate the glucose levels in their body. Normally this is where the body’s insulin-producing cells would respond to glucose ...
A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
The acceptance comes after a study done by the American Diabetes Association in June found that inhaled insulin is safe and ...
The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1.
Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the ...
Tests in animals show the material works like the body's own system. Post content hidden for low score. Show… Post content hidden for low score. Show… Seems like a pretty interesting idea. I know a ...
The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...
Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback